FDA/OSI Workshop Aims to Accelerate Osteosarcoma Drug Development
The U.S. Food and Drug Administration (FDA), the Osteosarcoma Institute (OSI), and others are coming together to shape the future of osteosarcoma clinical trials.
Stories of progress, inspiration, and information in overcoming osteosarcoma
No results found.
Sort By Category
The U.S. Food and Drug Administration (FDA), the Osteosarcoma Institute (OSI), and others are coming together to shape the future of osteosarcoma clinical trials.
For the Yela family, staying close has always been a way of life. That bond became essential when Dylan faced a life-changing diagnosis.
Chemotherapy and surgery are essential parts of osteosarcoma care — and both come with cancer treatment side effects that patients and families should be prepared to manage.
Veterinary oncologist Chand Khanna, DVM, PhD, explains how osteosarcoma in dogs is helping researchers unlock new possibilities for treating human patients.
How studying cancer in dogs is reshaping what we know about osteosarcoma in humans.
How an 18-year-old marching band musician is navigating life, treatment, and the path to young adulthood.
No results found.
Sign Up to Receive The Frontline
Stay informed as we work to identify new treatments for osteosarcoma.
We never sell or share your information.
More Stories of Hope
Supported by the Osteosarcoma Institute and Ethos Discovery, the MIMIC trial evaluates a new method of removing lung metastases in dogs, providing insights that can directly inform human osteosarcoma treatment and drug development.
What you need to understand to help a young person manage stress, depression, and the long-term psychological effects of cancer.
No results found.
We Want to Hear from You
Are you interested in helping us raise awareness and much-needed funds for research? Tell us your story!
Your donation provides immediate and long-term support to osteosarcoma patients.